GNMK - GenMark Diagnostics, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD

GenMark Diagnostics, Inc.

5964 La Place Court
Carlsbad, CA 92008
United States

IndustryMedical Appliances & Equipment
Full Time Employees308

Key Executives

Mr. Hany MassaranyChief Exec. Officer, Pres and Director834.32kN/A56
Mr. Scott MendelChief Financial Officer476.53kN/A50
Mr. Eric StierSr. VP, Gen. Counsel and Sec.349.89kN/A41
Ms. Jennifer WilliamsSr. VP of HR372.14kN/A44
Mr. Michael GleesonSr. VP of North American Commercial Operations372.14kN/A42
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular tests based on its proprietary eSensor electrochemical detection technology. The company provides XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents that enable reference laboratories and hospitals to support a range of molecular tests with a workstation and disposable test cartridges. It offers diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, warfarin sensitivity test, and thrombophilia risk test, as well as HCV genotyping test and associated custom manufactured reagents, and 2C19 genotyping test. The company also provides ePlex instrument and RP panel, which integrates automated nucleic acid extraction and amplification with its eSensor detection technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results without any additional steps. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.

Corporate Governance

GenMark Diagnostics, Inc.’s ISS Governance QualityScore as of February 1, 2018 is 8. The pillar scores are Audit: 2; Board: 5; Shareholder Rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.